Our values

  • Honesty & credibility
  • Unrelenting focus on delivery
  • Identifying with clients’ goals
  • Passion for science
  • Innovation


  • Bogusław Sieczkowski

    Bogusław Sieczkowski

    Chief Executive Officer

    Boguslaw Sieczkowski is a co-founder of Selvita and currently holds the position of the Chief Executive Officer. Mr. Sieczkowski has over 15 years of experience in management within the field of high-tech companies. His managerial experience includes roles at Bahlsen Group, Board Member at Comarch Internet Ventures S.A., Vice President at Comarch S.A., and most recently Chief Operating Officer and Executive Vice President at Selvita Group responsible for the full operational management of the Company.

    In 2013, Mr. Sieczkowski was awarded Knight’s Cross of the Order of Polonia Restituta for his contributions to the development of Poland’s business environment. He holds MBA title from joint programme of the University of Teesside (United Kingdom) and Krakow School of Economics (Poland), M.Sc. degree from Jagiellonian University in Krakow as well as Project Management Professional certificate issued by Project Management Institute (United States).

  • Miłosz Gruca

    Miłosz Gruca

    Executive Vice President,
    Director of Biology Department

    Milosz Gruca, Ph.D., has been associated with Selvita from its inception in 2007, responsible for the introduction of complex biological and analytical services to the company’s offer and subsequently strategic management of Analytical, Biochemistry, and Molecular Biology laboratories. He is also responsible for the creation and execution of company’s preclinical services offer, as well as for the scientific and strategic leadership of interdisciplinary teams of researchers within the largest department in the Selvita Group – Biology Department. As an Executive Vice President he is responsible for the operational management of the Biology Department, as well as company’s Business Development activities in Poland, Switzerland, U.K. and U.S. Dr. Milosz Gruca is a graduate of the Jagiellonian University, where he earned his M.Sc. degree in Biotechnology with specialization in Molecular Biology, and a Ph.D. degree in Biochemistry. He also holds an Executive MBA title from joint program at Stockholm University School of Business and the Krakow University of Economics Business School.

  • Mirosława Zydroń

    Mirosława Zydroń

    Member of the Management Board,
    Director of Chemistry Department

    Miroslawa Zydron, Ph.D. Eng., joined Selvita in December 2009, and has been responsible for the formation and organization of the Chemistry Department, strategic development of the chemistry research services, presentation of the company’s offer and building relationships with international clients from the pharmaceutical, biotechnology, chemical and agrochemical environments, as well as overseeing the ongoing projects to ensure the highest quality of services. Dr. Zydron gained her experience in project management, formation of research and development structures and management of R&D teams in Pliva (then: Barr Pharmaceuticals, TEVA), as Head of R&D Laboratory, overseeing analytical and preformulation activities at the stage of drug form development and packaging processes in pilot production in the GMP environment. Dr. Zydron graduated from the Silesian Technical University (Poland), with M.Sc. and Ph.D. degree in Chemistry. She also holds MBA title from the Rotterdam School of Management at Erasmus University in Rotterdam (Netherlands).

  • Edyta Jaworska

    Edyta Jaworska

    Member of the Management Board,
    Integrated Drug Discovery

    Edyta Jaworska joined Selvita in 2012, starting as a Business Development Manager responsible for the sales and development of Selvita offer in selected Western European countries. In 2014, she was promoted to the position of Business Development Director, taking over management of a sales team responsible for sales & development of Selvita services offer in Western Europe, Israel and Japan. As a Management Board member, she is now responsible for the development of Selvita integrated drug discovery services’ offer. Before she joined Selvita, she has gained several years of experience in managerial positions in various healthcare companies including OneMed group and International Nephrology Centers. Edyta Jaworska is a graduate of the University of Economics in Krakow, where she graduated with M.Sc. in Economics and Post-graduate studies diploma in Finance Management. She also studied at the University of Southern Denmark in Odense. She holds MBA title from Stockholm University and Krakow University of Economics joint program.

  • Dawid Radziszewski

    Dawid Radziszewski

    Member of the Management Board,
    General Counsel

    Dawid Radziszewski has joined Selvita in 2015 taking the position of an in-house lawyer overseeing company’s legal affairs. Since then he has been promoted to the position of General Counsel, and entrusted with an assignment to build and manage a company’s legal department. He is in charge of all legal matters, including in particular complex corporate issues, IP licensing transactions, as well as a corporate development of the Company. As a Management Board member, he is additionally responsible for Selvita’s activity in the field of mergers&acquisitions. Prior to joining Selvita, Dawid Radziszewski has gained several years of experience at one of the leading law firms WKB Wierciński, Kwieciński, Baehr, working in area of corporate law and M&A. Previous to that he was affiliated with the Allerhand Institute – an independent research centre, which conducts interdisciplinary and comparative studies on the role of legal institutions in economic markets. Laureate of the contest “Rising Stars – lawyers, leaders of tomorrow”, in 2018. Dawid Radziszewski is an advocate, a graduate of the Jagiellonian University and Heidelberg University where he earned his LL.M title. He has also studied at the University of Zurich.

  • Dariusz Kurdas

    Dariusz Kurdas

    Member of the Management Board,
    Financial Director

    Dariusz Kurdas joined Selvita in August 2019, taking the position of Financial Director, and assuming the responsibility for financial and operational activities at Selvita. Prior to joining Selvita, Dariusz spent several years at KPMG Audyt managing an audit team. He also held accounting and financial positions at Nowy Styl, Polish-based European leader in comprehensive office solutions with local structures in many countries around the world, where while executing financial controller responsibilities he was responsible for financial, accountancy and controlling support, budgets’ forecasting and control, as well as control of fulfilment of bank covenants of subsidiaries in Germany. In 2016, he joined Liugong Dressta Machinery where he held the position of Finance Director and subsequently, Chief Financial Officer, managing accounting, finance and controlling teams. Dariusz Kurdas graduated in Finance from Krakow University of Economics and Tilburg University (the Netherlands). He is a registered Public Certified Auditor and licensed stockbroker.

  • Piotr Romanowski

    Piotr Romanowski

    Chairman of the Supervisory Board

    Dr. Romanowski is a senior advisor and investor across biotech, deep tech and financial services. He is the Chairman of the Supervisory Board of Ryvu Therapeutics S.A. Previously, Dr. Romanowski has spent over 20 years in strategic management consulting as Partner in McKinsey & Company and PwC where he specialized in strategy and M&A in financial services, oil & gas, pharmaceuticals, and health care.

    Dr. Romanowski was also a Board Member at Bank Millennium S.A. responsible for Corporate and Investment Banking. He holds a Ph.D. in molecular biology from the University of Cambridge and MD, Ph.D. in cancer genetics from the Medical University of Gdańsk. Dr. Romanowski is a Member of the Audit Committee at Selvita.

  • Tadeusz Wesołowski

    Tadeusz Wesołowski

    Vice Chairman of the Supervisory Board

    Dr. Tadeusz Wesolowski received his PhD in Technical Sciences from Warsaw University of Technology. After receiving his diploma, he worked at the university as a lecturer. In 1990, he established and managed PROSPER company (part of NEUCA Group). Dr. Wesolowski consistently advised and participated in the creation of new ventures in the pharmaceutical market. Dr. Wesołowski is a Member of the Audit Committee at Selvita.

  • Pawel Przewięźlikowski

    Pawel Przewięźlikowski

    Supervisory Board Member

    Pawel Przewiezlikowski is currently Chief Executive Officer of Ryvu Therapeutics, biotechnology company developing innovative therapies that address clinical limitations of current treatments in oncology, which was founded upon the split of Selvita oncology development and research services divisions into separate companies. Przewiezlikowski is also the co-founder and former CEO of Selvita, who oversaw strategic management, business and corporate development of Selvita Group for over 12 years. He is also the President of the Board at Ardigen. Przewiezlikowski was a member of the executive team at Comarch technology company. He was also the co-founder of Interia.pl, Poland’s third largest internet portal. Mr. Przewięźlikowski holds an MBA from the Teesside University (UK) and Cracow University of Economics. He also holds a master degree in computer science from AGH Technical University in Krakow and studied IT at the Technical University in Berlin.

  • Rafał Chwast

    Rafał Chwast

    Supervisory Board Member

    Mr. Rafal Chwast is a graduate of Cracow University of Economics (Accounting) and the AGH Technical University in Krakow (Computer Science). From 1997-2007, he served as Vice President and Chief Financial Officer at Comarch. He was responsible for financial supervision of group’s subsidaries, raising capital through the stock exchange for Comarch and Interia.pl, and the acquisition of the CDN company. From 2003-2006, he served as CEO of the Association of Stock Exchange Issuers, and was also a member of the Capital Market Council operating at the Prime Minister. Mr. Chwast is the President of the Audit Committee at Selvita.

  • Wojciech Chabasiewicz

    Wojciech Chabasiewicz

    Supervisory Board Member

    Mr. Wojciech Chabasiewicz graduated from the Faculty of Law and Administration of Jagiellonian University and was entered on the list of Legal Counsels in 2005. Mr. Chabasiewicz specializes in corporate law, capital markets and securities, mergers and acquisitions, as well as in issues related to bankruptcy and restructuring. Between 2005 and 2009, he was a Partner at the law firm Tomasik, Chabasiewicz & Partners LP. He is currently a partner at the Chabasiewicz, Kowalska and Partners LP. Since the very beginning of his professional career, Mr. Chabasiewicz has been advising on the public and private stock and bond issues, mergers and acquisitions and restructuring transactions. He also deals with all types of investigations related to corporate conflicts. Additionally, Mr. Chabasiewicz is a Member of the Audit Committee at Selvita.

  • Jacek Osowski

    Jacek Osowski

    Supervisory Board Member

    Jacek Osowski is an investment adviser and auditor with ample experience in building investement strategies and overseeing equity transactions. From 2007–2008, he was the Vice President of the Management Board of IPOPEMA TFI S.A., Subsequently, he worked as the Deputy Director of the Treasurer’s Office at PZU S.A./PZU Życie S.A. (2008-2009). From 2009-2011, he was the Vice President of the Management Board, CIO, Director at PZU Asset Management S.A. Moreover, he was Famur S.A. management board member. Jacek Osowski is a graduate of the Warsaw School of Economics (banking and finance). He obtained an MBA degree at the University of Warsaw and the University of Illinois (2005-2006). Furthermore, Jacek Osowski holds investment adviser license and Chartered Financial Accountant (CFA) license. He is also on the list of statutory auditors.


Social Responsibility

Join Selvita Team!

We’re driven by a clear purpose - to help our clients with their research and ultimately improve peoples’ lives.

Send Your CV